These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
2. Extension of resistance to cefepime and cefpirome associated to a six amino acid deletion in the H-10 helix of the cephalosporinase of an Enterobacter cloacae clinical isolate. Barnaud G; Labia R; Raskine L; Sanson-Le Pors MJ; Philippon A; Arlet G FEMS Microbiol Lett; 2001 Feb; 195(2):185-90. PubMed ID: 11179650 [TBL] [Abstract][Full Text] [Related]
3. Expression of AmpC beta-lactamase in Enterobacter cloacae isolated from retail ground beef, cattle farm and processing facilities. Kim SH; Wei CI J Appl Microbiol; 2007 Aug; 103(2):400-8. PubMed ID: 17650200 [TBL] [Abstract][Full Text] [Related]
4. Emergence of a cefepime- and cefpirome-resistant Citrobacter freundii clinical isolate harbouring a novel chromosomally encoded AmpC beta-lactamase, CMY-37. Ahmed AM; Shimamoto T Int J Antimicrob Agents; 2008 Sep; 32(3):256-61. PubMed ID: 18619820 [TBL] [Abstract][Full Text] [Related]
5. Activity of avibactam against Enterobacter cloacae producing an extended-spectrum class C β-lactamase enzyme. Lahiri SD; Giacobbe RA; Johnstone MR; Alm RA J Antimicrob Chemother; 2014 Nov; 69(11):2942-6. PubMed ID: 24986496 [TBL] [Abstract][Full Text] [Related]
6. Screening extended-spectrum beta-lactamase production in Enterobacter cloacae and Serratia marcescens using antibiogram-based methods. Su PA; Wu LT; Cheng KC; Ko WC; Chuang YC; Yu WL J Microbiol Immunol Infect; 2010 Feb; 43(1):26-34. PubMed ID: 20434120 [TBL] [Abstract][Full Text] [Related]
7. Mutations in β-Lactamase AmpC Increase Resistance of Pseudomonas aeruginosa Isolates to Antipseudomonal Cephalosporins. Berrazeg M; Jeannot K; Ntsogo Enguéné VY; Broutin I; Loeffert S; Fournier D; Plésiat P Antimicrob Agents Chemother; 2015 Oct; 59(10):6248-55. PubMed ID: 26248364 [TBL] [Abstract][Full Text] [Related]
9. SHV-type extended-spectrum beta-lactamase production is associated with Reduced cefepime susceptibility in Enterobacter cloacae. Szabó D; Bonomo RA; Silveira F; Pasculle AW; Baxter C; Linden PK; Hujer AM; Hujer KM; Deeley K; Paterson DL J Clin Microbiol; 2005 Oct; 43(10):5058-64. PubMed ID: 16207962 [TBL] [Abstract][Full Text] [Related]
10. [Mechanisms of resistance in Enterobacteriaceae towards beta-lactamase antibiotics]. Susić E Acta Med Croatica; 2004; 58(4):307-12. PubMed ID: 15700687 [TBL] [Abstract][Full Text] [Related]
11. Genetic characterization of an extended-spectrum AmpC cephalosporinase with hydrolysing activity against fourth-generation cephalosporins in a clinical isolate of Enterobacter aerogenes selected in vivo. Rodríguez-Martínez JM; Fernández-Echauri P; Fernández-Cuenca F; Diaz de Alba P; Briales A; Pascual A J Antimicrob Chemother; 2012 Jan; 67(1):64-8. PubMed ID: 22001269 [TBL] [Abstract][Full Text] [Related]
12. Mutational replacement of Leu-293 in the class C Enterobacter cloacae P99 beta-lactamase confers increased MIC of cefepime. Vakulenko SB; Golemi D; Geryk B; Suvorov M; Knox JR; Mobashery S; Lerner SA Antimicrob Agents Chemother; 2002 Jun; 46(6):1966-70. PubMed ID: 12019116 [TBL] [Abstract][Full Text] [Related]
13. [Detection of plasmid-mediated carbapenem-hydrolyzing beta-lactamase KPC-2 in a strain of carbapenem-resistant Enterobacter cloacae]. Cai JC; Zhou HW; Chen GX; Zhang R Zhonghua Yi Xue Za Zhi; 2008 Jan; 88(2):135-8. PubMed ID: 18353225 [TBL] [Abstract][Full Text] [Related]
14. Differences in the resistant variants of Enterobacter cloacae selected by extended-spectrum cephalosporins. Fung-Tomc JC; Gradelski E; Huczko E; Dougherty TJ; Kessler RE; Bonner DP Antimicrob Agents Chemother; 1996 May; 40(5):1289-93. PubMed ID: 8723487 [TBL] [Abstract][Full Text] [Related]
15. [Phenotypic and genotypic characterization of resistance to third-generation cephalosporins in Enterobacter spp]. Bertona E; Radice M; Rodríguez CH; Barberis C; Vay C; Famiglietti A; Gutkind G Rev Argent Microbiol; 2005; 37(4):203-8. PubMed ID: 16502641 [TBL] [Abstract][Full Text] [Related]
16. Molecular characterization of extended-spectrum beta-lactamases produced by clinical isolates of Enterobacter cloacae from a Teaching Hospital in China. Liu G; Ling BD; Zeng Y; Lin L; Xie YE; Lei J Jpn J Infect Dis; 2008 Jul; 61(4):286-9. PubMed ID: 18653970 [TBL] [Abstract][Full Text] [Related]
17. ampR gene mutations that greatly increase class C beta-lactamase activity in Enterobacter cloacae. Kuga A; Okamoto R; Inoue M Antimicrob Agents Chemother; 2000 Mar; 44(3):561-7. PubMed ID: 10681318 [TBL] [Abstract][Full Text] [Related]
18. Diversity of chromosomal AmpC beta-lactamases from Enterobacter cloacae isolates in a Portuguese hospital. Conceição T; Faria N; Lito L; Melo Cristino J; Salgado MJ; Duarte A FEMS Microbiol Lett; 2004 Jan; 230(2):197-202. PubMed ID: 14757240 [TBL] [Abstract][Full Text] [Related]
19. [The expression of AmpC and extended-spectrum beta-lactamases among clinical isolates of enterobacter cloacae and its impact on antibiotics susceptibility]. She D; Liu Y Zhonghua Yi Xue Za Zhi; 2002 Oct; 82(19):1355-8. PubMed ID: 12509943 [TBL] [Abstract][Full Text] [Related]
20. Inhibitor-sensitive AmpC beta-lactamase variant produced by an Escherichia coli clinical isolate resistant to oxyiminocephalosporins and cephamycins. Doi Y; Wachino J; Ishiguro M; Kurokawa H; Yamane K; Shibata N; Shibayama K; Yokoyama K; Kato H; Yagi T; Arakawa Y Antimicrob Agents Chemother; 2004 Jul; 48(7):2652-8. PubMed ID: 15215122 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]